Adults 18 to 80, any sex, with Adherence, Medication or Transplantation, Kidney. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Kidney Transplant Patients Who Expressed an Understanding of the Term Immunosuppression Medication Adherence and the Importance Immunosuppression Medication Adherence Post TransplantPrimary· 4 months
Through a series of focus groups, the investigators will qualitatively explore kidney transplant patients' understanding of the terms immunosuppressant medication adherence and nonadherence. What importance do patients attach to adherence. Do patients understand that nonadherence may effect the outcome of the transplant. The focus groups will identify the common practical and perceptual barriers to adherence identified by transplant patients and the interventions kidney transplant patients have used to try and improve their adherence. The focus groups will identify which interventions patients
Good understaning of the term
Group
Value
95% CI
Focus Group
19
Good understanding risk of rejection / graft loss
Group
Value
95% CI
Focus Group
19
Number of Kidney Transplant Patients Who Identified Interventions to Support Immunosuppressant Medication AdherencePrimary· 4 months
Through a series of focus groups, the investigators will qualitatively explore kidney transplant patients' understanding of the terms immunosuppressant medication adherence and nonadherence. What importance do patients attach to adherence. Do patients understand that nonadherence may effect the outcome of the transplant. The focus groups will identify the common practical and perceptual barriers to adherence identified by transplant patients and the interventions kidney transplant patients have used to try and improve their adherence. The focus groups will identify which interventions patients
Medicines compliance aids, smart-phone apps
Group
Value
95% CI
Focus Group
14
Support provided to them by the MDT
Group
Value
95% CI
Focus Group
26
Use of alarms and apps
Group
Value
95% CI
Focus Group
15
Number of Patients Who Identify Barriers to Immunosuppression Medication AdherencePrimary· 4 months
Through a series of focus groups, the investigators will qualitatively explore kidney transplant patients' understanding of the terms immunosuppressant medication adherence and nonadherence. What importance do patients attach to adherence. Do patients understand that nonadherence may effect the outcome of the transplant. The focus groups will identify the common practical and perceptual barriers to adherence identified by transplant patients and the interventions kidney transplant patients have used to try and improve their adherence. The focus groups will identify which interventions patients
Forgetfulness / recall
Group
Value
95% CI
Focus Group
6
Ability to take at regular time / on emtpy stomach
Group
Value
95% CI
Focus Group
6
Adverse effects
Group
Value
95% CI
Focus Group
1
Sponsor's own description
To describe the beliefs, understanding and experience of immunosuppressant medication adherence in our current transplant patient population through a series of patient focus groups
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07129265 — Understanding Vape Marketing Study
· enrolling by invitation
NCT06562751 — Developing an Intervention to Help Nurses Improve Sexual Healthcare in Men With Inflammatory Bowel Disease
· completed
NCT06535802 — iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed
· recruiting
NCT05749406 — Parental Attitudes to Neoanus Dilatations Post-reconstruction in Anorectal Malformations
· unknown
NCT05925088 — Exercise Videos - Perspectives of People Living With Chronic Pain
· completed
Other recruiting trials for Adherence, Medication
Currently open trials in the same condition.
NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study
· NA
· recruiting
NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
· NA
· recruiting
NCT06056037 — Making ART Work Among Brazilian Youth
· NA
· recruiting
NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction
· active not recruiting
NCT05374109 — SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth
· NA
· active not recruiting
Other Imperial College London trials
Trials by the same sponsor.
NCT06035861 — Endothelial Cell Activation and Total Pulmonary Resistance in PAH
· NA
· not yet recruiting
NCT07397455 — Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants
· Phase 1
· not yet recruiting
NCT07422532 — A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing
· NA
· not yet recruiting
NCT07389031 — Maralixibat for Intrahepatic Cholestasis of Pregnancy
· Phase 2
· not yet recruiting
NCT07358897 — Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imperial College London
Last refreshed: 12 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03977051.